Based on immunohistochemical staining for TPX2 in 253 primary breast cancer tissues, Matson et al. proposed that higher TPX2 nuclear expression showed outstanding correlations with higher average ploidy, supernumerary centrosomes, and an elevated incidence of TP53 mutations (Matson et al. 2021). The gene discussed is TP53; the disease is breast cancer.